Financials
- Market Capitalization 9.8 B
- Employee 295
- Founded 2016
- CEO N/A
- Website www.krystalbio.com
- Headquarter Pennsylvania, United States
- FIGI BBG00HDGRHH7
- Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
36.04
Índice preço/fluxo de caixa
18.98
Related tickers
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 859 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 55.45 USD | +1.19% | -2.89% | -16.62% | +5.92% | 10.73 B USD | ||
| 890 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 80.35 USD | +0.71% | +4.80% | +3.16% | +102.67% | 10.22 B USD | ||
| 931 | KYMR Kymera Therapeutics, Inc. - Common Stock | 112.82 USD | +0.37% | +7.54% | -2.74% | +90.90% | 9.38 B USD | ||
| 933 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 148.33 USD | +3.20% | +6.38% | -1.06% | +97.43% | 9.60 B USD |